We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
80.67%
This Fund
S&P 500
This Quarter
Est. Return
+31.44%
1 Year Est. Return
+80.67%
3 Year Est. Return
+80.2%
5 Year Est. Return
+49.87%
10 Year Est. Return
+446.13%
AUM
$719M
AUM Growth
-$27.1M
(-3.6%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-29.53%
Top 10 Holdings %
Top 10 Hldgs %
66.29%
Holding
201
New
72
Increased
18
Reduced
27
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$7.93M |
| 2 |
FNB Corp
FNB
|
+$7.61M |
| 3 |
Sherwin-Williams
SHW
|
+$7.06M |
| 4 |
Allstate
ALL
|
+$5.58M |
| 5 |
Willis Towers Watson
WTW
|
+$5.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$274M |
| 2 |
Celanese
CE
|
+$6.41M |
| 3 |
MON
Monsanto Co
MON
|
+$6.27M |
| 4 |
Bunge Global
BG
|
+$5.97M |
| 5 |
Air Products & Chemicals
APD
|
+$4.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.96% |
| 2 | Financials | 20.91% |
| 3 | Industrials | 5.93% |
| 4 | Technology | 5.51% |
| 5 | Communication Services | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
IES Holdings
IESC
$12.4B
| – | – |
-48,154
| Closed | -$437K |
|
152
Incyte
INCY
$24.7B
| – | – |
-1,802
| Closed | -$227K |
|
153
Iovance Biotherapeutics
IOVA
$4.24B
| – | – |
-43,254
| Closed | -$318K |
|
154
Ingersoll Rand
IR
$27.9B
| – | – |
-72,147
| Closed | -$1.56M |
|
155
JetBlue
JBLU
$1.61B
| – | – |
-90,000
| Closed | -$2.06M |
|
156
Kirby Corp
KEX
$7.34B
| – | – |
-10,582
| Closed | -$707K |
|
157
LPL Financial
LPLA
$26.9B
| – | – |
-25,319
| Closed | -$1.07M |
|
158
Louisiana-Pacific
LPX
$4.53B
| – | – |
-24,607
| Closed | -$593K |
|
159
Moody's
MCO
$80.9B
| – | – |
-5,434
| Closed | -$661K |
|
160
MetLife
MET
$62.4B
| – | – |
-48,869
| Closed | -$2.39M |
|
161
Morgan Stanley
MS
$324B
| – | – |
-12,579
| Closed | -$561K |
|
162
Manitowoc
MTW
$741M
| – | – |
-24,986
| Closed | -$601K |
|
163
Nasdaq
NDAQ
$49.9B
| – | – |
-59,964
| Closed | -$1.43M |
|
164
Ingevity
NGVT
$2.33B
| – | – |
-24,056
| Closed | -$1.38M |
|
165
Puma Biotechnology
PBYI
$477M
| – | – |
-15,685
| Closed | -$1.37M |
|
166
Photronics
PLAB
$1.61B
| – | – |
-120,956
| Closed | -$1.14M |
|
167
SEI Investments
SEIC
$12.7B
| – | – |
-14,464
| Closed | -$778K |
|
168
Sarepta Therapeutics
SRPT
$2.19B
| – | – |
-61,410
| Closed | -$2.07M |
|
169
Simpson Manufacturing
SSD
$7.09B
| – | – |
-24,586
| Closed | -$1.07M |
|
170
Texas Capital Bancshares
TCBI
$4.25B
| – | – |
-39,000
| Closed | -$3.02M |
|
171
Trex
TREX
$4.44B
| – | – |
-113,404
| Closed | -$1.92M |
|
172
T. Rowe Price
TROW
$22.2B
| – | – |
-15,399
| Closed | -$1.14M |
|
173
Valvoline
VVV
$3.61B
| – | – |
-51,250
| Closed | -$1.22M |
|
174
NCR Voyix
VYX
$1.04B
| – | – |
-44,739
| Closed | -$1.12M |
|
175
Zimmer Biomet
ZBH
$18.8B
| – | – |
-5,562
| Closed | -$693K |
|
Similar funds
OM
ICCON
HCM
ETCM
IDBONY
PCM
TCDRS
FPAM
Crestline Management's Q3 2017 Portfolio in Review
As of Q3 2017, Crestline Management held 201 positions worth $719M, down 3.6% from $746M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Crestline Management withdrew a net $212M in Q3 2017, closing 81 positions and reducing 27 holdings. Its most notable exit was Celanese, an estimated $6.41M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 76% a quarter earlier, followed by Financials and Industrials.
Against the trend, Crestline Management opened a new position in Travelers Companies worth $7.78M.
- Crestline Management's largest Q3 2017 buy was Travelers Companies: 63,503 shares worth $7.78M.
- Crestline Management added most to FNB Corp in Q3 2017, an estimated $7.61M increase.
- Crestline Management's biggest Q3 2017 reduction was Juno Therapeutics, Inc., cutting an estimated $274M.
- Crestline Management fully exited Celanese in Q3 2017, selling an estimated $6.41M.
- Crestline Management's ten largest holdings make up 66% of its $719M portfolio in Q3 2017.
- Crestline Management opened 72 new positions and closed 81 in Q3 2017.
- Crestline Management's portfolio value fell 3.6% quarter-over-quarter to $719M.
Based on Crestline Management's 13F filing for Q3 2017, filed 14 Nov 2017.